DSP-1181: drug created using AI enters clinical trials
The developers of DSP-1181, a drug created using AI, announced…
The developers of DSP-1181, a drug created using AI, announced that it has entered a Phase I clinical trial for the treatment of obsessive-compulsive disorder (OCD).